Welcome and Introduction (ID 5931)
Modern Approaches in the Treatment of ER+/HER2- Breast Cancer: Understanding the Biology and Foundational Concepts (ID 5932)
ER+/HER2- Breast Cancer Pre-Treated With EndocrineTherapy as an Inflection Point: Unmet Needs and Novel Rational Treatment Strategies (ID 5933)
Emerging Options in the Treatment of ER+/HER2- Breast Cancer: The Expanding Evidence Base on Oral SERDs and Other ER-Targeting Agents (ID 5934)
Accelerating Progress in the Treatment of Previously Treated ER+HER2- Breast Cancer With Novel Therapies: Translating Research Advances to Improvements in Practice (ID 5935)
